<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://eln.excellgen.com/index.php?action=history&amp;feed=atom&amp;title=Antibody_for_Diagnostics</id>
	<title>Antibody for Diagnostics - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://eln.excellgen.com/index.php?action=history&amp;feed=atom&amp;title=Antibody_for_Diagnostics"/>
	<link rel="alternate" type="text/html" href="https://eln.excellgen.com/index.php?title=Antibody_for_Diagnostics&amp;action=history"/>
	<updated>2026-10-18T03:29:53Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.0</generator>
	<entry>
		<id>https://eln.excellgen.com/index.php?title=Antibody_for_Diagnostics&amp;diff=19090&amp;oldid=prev</id>
		<title>Paul.xu: Created page with &quot;{| border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;1&quot; style=&quot;width: 968px;&quot; |- | Supplier | Cat # | Name | Clone | Price | style=&quot;width: 486px;&quot; | Application | style=&quot;width: 40px;&quot; |...&quot;</title>
		<link rel="alternate" type="text/html" href="https://eln.excellgen.com/index.php?title=Antibody_for_Diagnostics&amp;diff=19090&amp;oldid=prev"/>
		<updated>2018-08-21T14:12:06Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;{| border=&amp;quot;1&amp;quot; cellspacing=&amp;quot;1&amp;quot; cellpadding=&amp;quot;1&amp;quot; style=&amp;quot;width: 968px;&amp;quot; |- | Supplier | Cat # | Name | Clone | Price | style=&amp;quot;width: 486px;&amp;quot; | Application | style=&amp;quot;width: 40px;&amp;quot; |...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{| border=&amp;quot;1&amp;quot; cellspacing=&amp;quot;1&amp;quot; cellpadding=&amp;quot;1&amp;quot; style=&amp;quot;width: 968px;&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| Supplier&lt;br /&gt;
| Cat #&lt;br /&gt;
| Name&lt;br /&gt;
| Clone&lt;br /&gt;
| Price&lt;br /&gt;
| style=&amp;quot;width: 486px;&amp;quot; | Application&lt;br /&gt;
| style=&amp;quot;width: 40px;&amp;quot; | ID&lt;br /&gt;
| style=&amp;quot;width: 155px;&amp;quot; | Long name&lt;br /&gt;
| style=&amp;quot;width: 17px;&amp;quot; | Status&lt;br /&gt;
|-&lt;br /&gt;
| Hytest&lt;br /&gt;
| 4NT4cc&lt;br /&gt;
| NT-proBNP&lt;br /&gt;
| 15F11cc&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 486px;&amp;quot; | patients with heart failure, unstable angina and myocardial infarction.&amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 40px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 155px;&amp;quot; | N-terminal pro-brain natriuretic peptide&amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 17px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| Hytest&amp;lt;br/&amp;gt;&lt;br /&gt;
| 4NT4cc&amp;lt;br/&amp;gt;&lt;br /&gt;
| NT-proBNP&amp;lt;br/&amp;gt;&lt;br /&gt;
| 24E11cc&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 486px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 40px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 155px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 17px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| Hytest&amp;lt;br/&amp;gt;&lt;br /&gt;
| 4F29&lt;br /&gt;
| FABP&lt;br /&gt;
| 9F3&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 486px;&amp;quot; | myocardial injury in early stage.&amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 40px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 155px;&amp;quot; | anti-human fatty acid binding protein (FABP)&amp;amp;nbsp;heart-type fatty acid-binding protein&amp;amp;nbsp;&amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 17px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| Hytest&amp;lt;br/&amp;gt;&lt;br /&gt;
| 4F29&amp;lt;br/&amp;gt;&lt;br /&gt;
| FABP&amp;lt;br/&amp;gt;&lt;br /&gt;
| 10E1&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 486px;&amp;quot; | myocardial injury in early stage.&amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 40px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 155px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 17px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| Hytest&amp;lt;br/&amp;gt;&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 486px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 40px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 155px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 17px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| Hytest&amp;lt;br/&amp;gt;&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 486px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 40px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 155px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
| style=&amp;quot;width: 17px;&amp;quot; | &amp;lt;br/&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{| border=&amp;quot;1&amp;quot; cellspacing=&amp;quot;1&amp;quot; cellpadding=&amp;quot;1&amp;quot; style=&amp;quot;width: 968px;&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| FABP&lt;br /&gt;
|}&lt;br /&gt;
[[Category:Antibodies]]&lt;/div&gt;</summary>
		<author><name>Paul.xu</name></author>
	</entry>
</feed>